Vimarsana
Biggest News Aggregation in the World

Page 44 - Nuclear Technologies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nuclear Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nuclear Technologies Today - Breaking & Trending Today

Miller Honored for Decades of Service to LLNL, National Security - Vimarsana News

Miller Honored for Decades of Service to LLNL, National Security

Laboratory director emeritus George Miller recently was awarded the sixth John S. Foster, Jr. Medal for his long service to Lawrence Livermore National Laboratory (LLNL) and contributions to the nation’s

Science and security: W&M alum George Miller awarded John S. Foster Medal - Vimarsana News

Science and security: W&M alum George Miller awarded John S. Foster Medal

George Miller ’67, M.S. ’69, Ph.D. ’72 was honored with the John S. Foster Medal for his contributions to national security.

Source: wm.edu
Miller receives John S. Foster Jr. Medal in honor of decades of iconic service - Vimarsana News

Miller receives John S. Foster Jr. Medal in honor of decades of iconic service

John S. “Johnny” Foster, Jr. (left) applauds his fellow Laboratory director emeritus, 2021 Foster Medal recipient George Miller (right) in a ceremony

China Set to Have 1,000 Nuclear Warheads by 2030, Pentagon Report Warns - Vimarsana News

China Set to Have 1,000 Nuclear Warheads by 2030, Pentagon Report Warns

China is on track to have 700 deliverable nuclear missiles by 2027, and could have as many as 1,000 by 2030, according to a new report by the Pentagon.

Rafarma To Expand Proton Therapy Centers - Vimarsana News

Rafarma To Expand Proton Therapy Centers

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Rafarma To Expand Proton Therapy Centers RAFARMA PHARMACEUTICALS INCMay 7, 2021 GMT Nicosia, Cyprus, May 07, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce that RAFA is in active meetings the City Scientific University of Istanbul (Turkey) ( https://cerrahpasa.istanbulc.edu.tr ) to establish a nuclear medicine and proton therapy center at the university. In developed countries, up to 70% of cancer patients undergo proton therapy annually and Rafarma received...

Source: apnews.com